IL74459A - Controlled release pharmaceutical compositions containing bromocriptine - Google Patents

Controlled release pharmaceutical compositions containing bromocriptine

Info

Publication number
IL74459A
IL74459A IL74459A IL7445985A IL74459A IL 74459 A IL74459 A IL 74459A IL 74459 A IL74459 A IL 74459A IL 7445985 A IL7445985 A IL 7445985A IL 74459 A IL74459 A IL 74459A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
controlled release
compositions containing
release pharmaceutical
containing bromocriptine
Prior art date
Application number
IL74459A
Other languages
English (en)
Other versions
IL74459A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL74459A0 publication Critical patent/IL74459A0/xx
Publication of IL74459A publication Critical patent/IL74459A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL74459A 1984-02-29 1985-02-27 Controlled release pharmaceutical compositions containing bromocriptine IL74459A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions

Publications (2)

Publication Number Publication Date
IL74459A0 IL74459A0 (en) 1985-05-31
IL74459A true IL74459A (en) 1988-12-30

Family

ID=10557324

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74459A IL74459A (en) 1984-02-29 1985-02-27 Controlled release pharmaceutical compositions containing bromocriptine

Country Status (26)

Country Link
JP (1) JPS60202812A (xx)
AT (1) AT387716B (xx)
AU (2) AU586621B2 (xx)
BE (1) BE901810A (xx)
CA (1) CA1256374A (xx)
CH (2) CH666406A5 (xx)
DE (1) DE3505743C2 (xx)
DK (1) DK175016B1 (xx)
ES (1) ES8705223A1 (xx)
FR (1) FR2560047B1 (xx)
GB (1) GB8405227D0 (xx)
GR (1) GR850506B (xx)
HK (1) HK85490A (xx)
HU (1) HU196121B (xx)
IE (1) IE58235B1 (xx)
IL (1) IL74459A (xx)
IT (1) IT1199948B (xx)
LU (1) LU85791A1 (xx)
MX (1) MX9203626A (xx)
NL (1) NL194231C (xx)
NZ (1) NZ211247A (xx)
PH (1) PH23266A (xx)
PT (1) PT80015B (xx)
SE (2) SE8500961L (xx)
SG (1) SG69390G (xx)
ZA (1) ZA851546B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
EP0689424B1 (en) * 1993-03-17 1998-10-14 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128902C (xx) * 1960-06-06
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
PT80015B (pt) 1987-09-18
NL194231C (nl) 2001-10-02
ES8705223A1 (es) 1987-05-01
CH667009A5 (de) 1988-09-15
JPH0448776B2 (xx) 1992-08-07
DE3505743C2 (de) 1995-02-16
IT8547703A1 (it) 1986-08-20
NZ211247A (en) 1989-02-24
IE850495L (en) 1985-08-29
MX9203626A (es) 1992-09-01
GR850506B (xx) 1985-06-28
LU85791A1 (fr) 1985-12-11
SE8500961L (sv) 1985-08-30
GB8405227D0 (en) 1984-04-04
AT387716B (de) 1989-03-10
PH23266A (en) 1989-06-23
IE58235B1 (en) 1993-08-11
SE8500961D0 (sv) 1985-02-27
DK86785A (da) 1985-08-30
AU618599B2 (en) 1992-01-02
HK85490A (en) 1990-10-25
HU196121B (en) 1988-10-28
NL194231B (nl) 2001-06-01
IL74459A0 (en) 1985-05-31
JPS60202812A (ja) 1985-10-14
CH666406A5 (de) 1988-07-29
AU3913685A (en) 1985-09-05
DK175016B1 (da) 2004-04-26
PT80015A (pt) 1986-02-10
DE3505743A1 (de) 1985-08-29
IT1199948B (it) 1989-01-05
ATA58085A (de) 1988-08-15
IT8547703A0 (it) 1985-02-20
HUT38254A (en) 1986-05-28
AU586621B2 (en) 1989-07-20
DK86785D0 (da) 1985-02-26
AU3500689A (en) 1989-09-14
SE462259B (sv) 1990-05-28
NL8500417A (nl) 1985-09-16
FR2560047B1 (fr) 1988-01-15
BE901810A (fr) 1985-08-26
SG69390G (en) 1990-10-26
ES540807A0 (es) 1987-05-01
ZA851546B (en) 1986-10-29
CA1256374A (en) 1989-06-27
FR2560047A1 (fr) 1985-08-30

Similar Documents

Publication Publication Date Title
GB8526591D0 (en) Controlled release powder & process
IL80643A0 (en) Controlled release pharmaceutical compositions
GB8721936D0 (en) Composition
GB2160771B (en) Composition for oral application
ZA88637B (en) Fire-resitant composition
IL77138A0 (en) Pharmaceutical compositions containing 1-heteroaryl-4-arylpyrazolin-5-ones
EP0318899A3 (en) Release agent composition
ZA859731B (en) Pharmaceutical compositions containing tetrahydrobenzthiazoles
EP0292963A3 (en) Fiber-treatment composition
GB2203336B (en) Composition
CY1564A (en) Bromocriptine compositions
HUT51856A (en) Mollusquicid composition
GB8715191D0 (en) Composition
ZA882963B (en) New ophtalmological composition of matter
EG18594A (en) Shampo composition
GB8523491D0 (en) Medicinal composition
IL74459A (en) Controlled release pharmaceutical compositions containing bromocriptine
GB8411355D0 (en) Controlled time release therapeutic composition
GB8712396D0 (en) Composition of matter
GB2199774B (en) Application for crease-setting composition
GB8521221D0 (en) Controlled release formulations
EP0321786A3 (en) Composition for external application
JPS6460631A (en) Polyfluoroalkoxyphosphazene composition
GB8724192D0 (en) Composition of matter
BG39018A1 (en) Composition for phenoplastics

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
EXP Patent expired